(3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole

C53H80BCl4N15O5 — CID 167652882

IUPAC(3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
SMILESC.C.C[C@@H]1COCCN1c1cc(Cl)nc(Cl)n1.Cc1nn(C)c(C)c1-c1cc(N2CCOC[C@H]2C)nc(Cl)n1.Cc1nn(C)c(C)c1-c1nc(Cl)cc(N2CCOC[C@H]2C)n1.Cc1nn(C)c(C)c1B1OC(C)(C)C(C)(C)O1
InChIInChI=1S/2C15H20ClN5O.C12H21BN2O2.C9H11Cl2N3O.2CH4/c1-9-8-22-6-5-21(9)13-7-12(16)17-15(18-13)14-10(2)19-20(4)11(14)3;1-9-8-22-6-5-21(9)13-7-12(17-15(16)18-13)14-10(2)19-20(4)11(14)3;1-8-10(9(2)15(7)14-8)13-16-11(3,4)12(5,6)17-13;1-6-5-15-3-2-14(6)8-4-7(10)12-9(11)13-8;;/h2*7,9H,5-6,8H2,1-4H3;1-7H3;4,6H,2-3,5H2,1H3;2*1H4/t2*9-;;6-;;/m11.1../s1
InChIKeyQVHRNTGFHCSYJN-OHNVJYEJSA-N
MW1159.95 g/mol
LogP9.36
Rot. Bonds6

About (3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole

(3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole (PubChem CID 167652882) has the molecular formula C53H80BCl4N15O5 and a molecular weight of 1159.95 g/mol. Its IUPAC name is (3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole.

Molecular Properties

Compound Name(3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
PubChem CID167652882
Molecular FormulaC53H80BCl4N15O5
Molecular Weight1159.95 g/mol
Exact Mass1157.53
IUPAC Name(3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole
SMILESC.C.C[C@@H]1COCCN1c1cc(Cl)nc(Cl)n1.Cc1nn(C)c(C)c1-c1cc(N2CCOC[C@H]2C)nc(Cl)n1.Cc1nn(C)c(C)c1-c1nc(Cl)cc(N2CCOC[C@H]2C)n1.Cc1nn(C)c(C)c1B1OC(C)(C)C(C)(C)O1
InChIInChI=1S/2C15H20ClN5O.C12H21BN2O2.C9H11Cl2N3O.2CH4/c1-9-8-22-6-5-21(9)13-7-12(16)17-15(18-13)14-10(2)19-20(4)11(14)3;1-9-8-22-6-5-21(9)13-7-12(17-15(16)18-13)14-10(2)19-20(4)11(14)3;1-8-10(9(2)15(7)14-8)13-16-11(3,4)12(5,6)17-13;1-6-5-15-3-2-14(6)8-4-7(10)12-9(11)13-8;;/h2*7,9H,5-6,8H2,1-4H3;1-7H3;4,6H,2-3,5H2,1H3;2*1H4/t2*9-;;6-;;/m11.1../s1
InChIKeyQVHRNTGFHCSYJN-OHNVJYEJSA-N
XLogP9.36
TPSA186.67 Ų
H-Bond Donors
H-Bond Acceptors20
Rotatable Bonds6
Heavy Atoms78
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001159.95
LogP ≤ 59.36
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze (3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole?
The IUPAC name of (3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole (CID 167652882) is (3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole.
What is the SMILES notation for (3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole?
The canonical SMILES for (3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole is C.C.C[C@@H]1COCCN1c1cc(Cl)nc(Cl)n1.Cc1nn(C)c(C)c1-c1cc(N2CCOC[C@H]2C)nc(Cl)n1.Cc1nn(C)c(C)c1-c1nc(Cl)cc(N2CCOC[C@H]2C)n1.Cc1nn(C)c(C)c1B1OC(C)(C)C(C)(C)O1.
What is the InChIKey of (3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole?
The InChIKey is QVHRNTGFHCSYJN-OHNVJYEJSA-N. The full InChI is InChI=1S/2C15H20ClN5O.C12H21BN2O2.C9H11Cl2N3O.2CH4/c1-9-8-22-6-5-21(9)13-7-12(16)17-15(18-13)14-10(2)19-20(4)11(14)3;1-9-8-22-6-5-21(9)13-7-12(17-15(16)18-13)14-10(2)19-20(4)11(14)3;1-8-10(9(2)15(7)14-8)13-16-11(3,4)12(5,6)17-13;1-6-5-15-3-2-14(6)8-4-7(10)12-9(11)13-8;;/h2*7,9H,5-6,8H2,1-4H3;1-7H3;4,6H,2-3,5H2,1H3;2*1H4/t2*9-;;6-;;/m11.1../s1.
What are the key properties of (3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole?
(3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole has a molecular weight of 1159.95 g/mol, XLogP of 9.36, 6 rotatable bonds, 0 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-4-[2-chloro-6-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-[6-chloro-2-(1,3,5-trimethylpyrazol-4-yl)pyrimidin-4-yl]-3-methylmorpholine;(3R)-4-(2,6-dichloropyrimidin-4-yl)-3-methylmorpholine;methane;1,3,5-trimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole is sourced from PubChem (CID 167652882), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).